Schonfeld Strategic Advisors LLC Amneal Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.33 - $3.1 $399 - $930	-300 Reduced 1.25%	23,700 $73,000
Q1 2023 May 15, 2023	SELL	$1.27 - $2.7 $6,223 - $13,230	-4,900 Reduced 16.96%	24,000 $33,000
Q4 2022 Feb 14, 2023	SELL	$1.96 - $2.61 $6,765 - $9,009	-3,452 Reduced 10.67%	28,900 $57,000
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $65,351 - $117,114	32,352 New	32,352 $65,000
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $315,223 - $419,886	-61,567 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $128,297 - $199,754	27,067 Added 78.46%	61,567 $414,000
Q4 2020 Feb 16, 2021	BUY	$3.95 - $5.42 $136,275 - $186,990	34,500 New	34,500 $157,000
Q4 2018 Feb 14, 2019	SELL	$13.09 - $21.49 $2.47 Million - $4.06 Million	-188,700 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.4 - $24.27 $2.06 Million - $3.05 Million	125,828 Added 200.13%	188,700 $4.19 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $877,064 - $1.27 Million	62,872 New	62,872 $1.03 Million

189

140M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.31B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.